Mo. Marshall et al., CONTRIBUTION OF GLUTAMATE-DECARBOXYLASE ANTIBODIES TO THE REACTIVITY OF ISLET-CELL CYTOPLASMIC ANTIBODIES, Journal of autoimmunity, 7(4), 1994, pp. 497-508
The contribution of glutamate decarboxylase (Mr 65000) antibodies to t
he reactivity of islet cell cytoplasmic antibodies with the 'whole' is
let staining pattern from patients with newly diagnosed Type I diabete
s was investigated. Diluted sera (n=10) were preincubated with increas
ing concentrations of purified recombinant human islet glutamate decar
boxylase (Mr 65000) and the change in islet cell cytoplasmic antibody
binding was evaluated by quantitative immunocytochemistry. Binding to
islet cells was partially blocked by glutamate decarboxylase in 9/10 d
iluted sera; the maximum blocking obtained at high concentrations of g
lutamate decarboxylase (5 mug/ml) was 36% (median, range 24-61%). In c
ontrast, binding to islet cells in three diluted sera (two polyendocri
ne patients without Type I diabetes and one patient with newly diagnos
ed Type I diabetes) with the 'selective' islet staining pattern was to
tally blocked by glutamate decarboxylase. The concentration of glutama
te decarboxylase required to achieve maximum blocking was less for the
'whole' islet (0.4-8.0 mug/mul undiluted serum) compared to the 'sele
ctive' islet (20-645 mug/mul undiluted serum) positive sera. All sera
were positive for glutamate decarboxylase antibodies in an immunopreci
pitation assay using S-35-methionine labelled extract of baby hamster
kidney cells transfected with glutamate decarboxylase. However, the bi
nding activity of these antibodies was less in the sera positive for t
he 'whole' islet compared to the 'selective' islet staining pattern. I
n conclusion, glutamate decarboxylase antibodies contribute partially
to the reactivity of islet cell cytoplasmic antibodies of the 'whole'
islet staining pattern in the sera of newly diagnosed patients with Ty
pe I diabetes, and totally to the reactivity of the 'selective' islet
staining pattern. The antigens recognized by the other antibodies cont
ributing to the 'whole' islet reactivity remain to be defined.